News on Hodgkin_Disease from BioPortfolio.com http://www.BioPortfolio.com Consolidated Hodgkin_Disease news from BioPortfolio.com Wed, 10 Feb 2010 09:42:47 GMT en Seattle Genetics and Millennium Announce Initiation of Phase I Combination Clinical Trial of Brentuximab Vedothttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036670&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036670&THISHREF=http://c.moreover.com/click/here.pl%3fz2536700451%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAmerican Pharmaceutical Outsourcing: Affimed Therapeutics AG (DE) - Affimed successfully completes preclinical development of AFM 13http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033207&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033207&THISHREF=http://c.moreover.com/click/here.pl%3fz2535065614%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033207&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033207&THISHREF=http://c.moreover.com/click/here.pl%3fz2535065614%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Cell Therapeutics stock plunges Monday on negative FDA review of cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038528&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038528&THISHREF=http://c.moreover.com/click/here.pl%3fz2537645718%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038528&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038528&THISHREF=http://c.moreover.com/click/here.pl%3fz2537645718%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeattle Times: Seahawks CEO: Paul Allen cancer tests encouraginghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038014&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038014&THISHREF=http://c.moreover.com/click/here.pl%3fz2537431970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038014&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038014&THISHREF=http://c.moreover.com/click/here.pl%3fz2537431970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMyNorthwest.com: FDA Postpones Panel Meeting To Review Cell Therapeutics' Drug Due To Extreme Weather - Updatehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033958&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033958&THISHREF=http://c.moreover.com/click/here.pl%3fz2535510771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033958&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033958&THISHREF=http://c.moreover.com/click/here.pl%3fz2535510771%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comRTTNews.com: Cost Effectiveness of Positron Emission Tomography in Patients With Hodgkin's Lymphoma in Unconfirmed Completehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033631&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033631&THISHREF=http://c.moreover.com/click/here.pl%3fz2535297820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033631&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033631&THISHREF=http://c.moreover.com/click/here.pl%3fz2535297820%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comJournal of Clinical Oncology: Cell Therapeutics stock plunges on negative FDA review of cancer drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033480&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033480&THISHREF=http://c.moreover.com/click/here.pl%3fz2535226444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeattle Times: Cell Therapeutics, AstraZeneca lead drug stockshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037960&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537397049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037960&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037960&THISHREF=http://c.moreover.com/click/here.pl%3fz2537397049%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Low-Dose Radiation for Hodgkin's Lymphoma Leaves Kids at High Risk for Second Cancershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037375&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037375&THISHREF=http://c.moreover.com/click/here.pl%3fz2537047225%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037375&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037375&THISHREF=http://c.moreover.com/click/here.pl%3fz2537047225%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAbstracts in Hematology and Oncology: Low-Dose Radiation for Hodgkin's Lymphoma Leaves Kids at High Risk for Second Cancershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037301&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037301&THISHREF=http://c.moreover.com/click/here.pl%3fz2537015655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037301&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037301&THISHREF=http://c.moreover.com/click/here.pl%3fz2537015655%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedscape: Low-Dose Radiation for Hodgkin's Lymphoma Leaves Kids at High Risk for Second Cancershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037261&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037261&THISHREF=http://c.moreover.com/click/here.pl%3fz2537001113%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037261&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037261&THISHREF=http://c.moreover.com/click/here.pl%3fz2537001113%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGeneral Medicine eJournal: Low-dose radiation for Hodgkin's lymphoma leaves kids at high risk for second cancershttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037185&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037185&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937974%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037185&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037185&THISHREF=http://c.moreover.com/click/here.pl%3fz2536937974%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAunt Minnie: FDA Postpones Oncologic Drugs Advisory Committee Meeting to Review Pixantrone Due to Severe Weather Conditionshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036391&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036391&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036391&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036391&THISHREF=http://c.moreover.com/click/here.pl%3fz2536596764%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Biotech Stocks: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036012&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036012&THISHREF=http://c.moreover.com/click/here.pl%3fz2536463997%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: Drug stocks gain; Cell Therapeutics reboundshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035768&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Hodgkin_Disease&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035768&THISHREF=http://c.moreover.com/click/here.pl%3fz2536363185%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMarketWatch: